Clinical Trials
3 trialsNCT00031083 2020-11-17
Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas
Biogen
Phase 1 Completed
NCT02530047 2019-07-18
Mesenchymal Stem Cells (MSC) for Ovarian Cancer
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00085306 2015-10-02
Interferon Beta in Treating Patients With Metastatic Cutaneous Melanoma or Ocular Melanoma
Case Comprehensive Cancer Center
Phase 2 Completed